- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Maat Pharma SA (MAAT)
Track today's live Maat Pharma (MAAT) share price, performance and key data on this page with our current Paris:MAAT stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Maat Pharma share price on the Paris exchange. Use the dropdown to switch exchange for the MAAT share price, head to our technical summary section, which provides analysis on Maat Pharma share price buy/sell indicators using real-time data (or discuss the Maat Pharma (MAAT) stock price today with other investors in the Maat Pharma EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA:MAAT share price (ISIN: FR0012634822) to enhance your trading decisions with our free investment tools and resources.
What Is the Maat Pharma SA Share Price Today?
The Maat Pharma share price today is 2.44.
What Is the Stock Symbol for Maat Pharma SA
The stock symbol (or 'ticker') for Maat Pharma SA is "MAAT."
What Stock Exchange Does Maat Pharma SA Trade On?
Maat Pharma SA is listed and trades on the Paris stock exchange.
Is Maat Pharma SA a Good Stock to Buy?
Determining whether Maat Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current EPA:MAAT share price (ISIN: FR0012634822) to enhance your trading decisions with our free investment tools and resources.
What Is the Maat Pharma SA Share Price Today?
The Maat Pharma share price today is 2.44.
What Is the Stock Symbol for Maat Pharma SA
The stock symbol (or 'ticker') for Maat Pharma SA is "MAAT."
What Stock Exchange Does Maat Pharma SA Trade On?
Maat Pharma SA is listed and trades on the Paris stock exchange.
Is Maat Pharma SA a Good Stock to Buy?
Determining whether Maat Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
2.44
+0.06(+2.31%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.33
2.44
52 wk Range
2.32
8.62
MAAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.332.44
52 wk Range
2.328.62
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MAAT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
6.50
Upside
+166.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.50
(+166.39% Upside)
Earnings
Latest Release
26/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
800K / --
Compare MAAT to Peers and Sector
Metrics to compare | MAAT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMAATPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −3.1x | −0.4x | |
PEG Ratio | −0.12 | −0.05 | 0.00 | |
Price/Book | 24.9x | 0.0x | 2.6x | |
Price / LTM Sales | 9.9x | 21.0x | 3.0x | |
Upside (Analyst Target) | 173.1% | 193.7% | 53.6% | |
Fair Value Upside | Unlock | −4.9% | 7.6% | Unlock |
MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in pivotal phase 3 clinical trial for the treatment of acute graft versus host diseases with gastrointestinal involvement; MaaT033, which is in phase 2b clinical trial for the improvement of survival at 12 months for patients with blood cancer receiving allogenic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors, as well as MaaT034 that optimize immune checkpoint inhibitor treatment. MaaT Pharma SA was incorporated in 2014 and is headquartered in Lyon, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Maat Pharma (Paris: MAAT) Share Price Today?
The Maat Pharma stock price today is 2.44 EUR.
What Stock Exchange Does Maat Pharma (MAAT) Trade On?
Maat Pharma is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Maat Pharma?
The stock symbol (also called a 'ticker') for Maat Pharma is "MAAT."
What Is the Current Maat Pharma Market Capitalisation?
As of today, Maat Pharma (Paris: MAAT) market cap is 44.85M EUR.
What Is Maat Pharma's (MAAT) Earnings Per Share (TTM)?
The Maat Pharma EPS is currently -1.95 (Trailing Twelve Months).
When Is the Next Maat Pharma Earnings Date?
Maat Pharma's next earnings report will be released on 29/09/2026.
Is MAAT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Maat Pharma moving averages and other technical indicators, the daily buy/sell signal for MAAT stock is Strong Sell.
How Many Times Has Maat Pharma Stock Split?
Maat Pharma has split 0 times. (See the MAAT stock split history page for full effective split date and price information.)
How Many Employees Does Maat Pharma Have?
Maat Pharma has 56 employees, based on their latest Companies House report.
What is the current trading status of Maat Pharma (Paris: MAAT)?
As of 01/07/2026, Maat Pharma (MAAT) is trading at a share price of 2.44 EUR, with a previous close of 2.38 EUR. The stock has fluctuated within a day range of 2.33 EUR to 2.44 EUR, while its 52-week range spans from 2.32 EUR to 8.62 EUR.
What Is Maat Pharma (MAAT) Price Target According to Analysts?
The average 12-month price target for Maat Pharma is 6.50 EUR, with a high estimate of 10 EUR and a low estimate of 3 EUR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +166.39% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.